Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models
Pancreatic cancer is a highly lethal solid malignancy with limited treatment options. Chimeric antigen receptor T (CAR-T) cell therapy has been successfully applied to treat hematological malignancies, but faces many challenges in solid tumors. One major challenge is the shortage of tumor-selective...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2024-01-01
|
| Col·lecció: | Translational Oncology |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S1936523323001894 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
